Advertisement

Topics

James (Jim) Skippen to Retire from Quarterhill Management

06:31 EDT 14 Jun 2018 | BioMedReports - Blog

Among Mr. Skippen's many accomplishments are the following:

  1. Signing more than 500 patent license agreements.
  2. Generating patent licenses worth in excess of $1B CDN.

Read more...

Original Article: James (Jim) Skippen to Retire from Quarterhill Management

NEXT ARTICLE

More From BioPortfolio on "James (Jim) Skippen to Retire from Quarterhill Management"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...